Prescription, OTC or Research Chemical: Telling Them Apart

A peptide name is just a molecule. The same name can appear on a prescription product dispensed by a pharmacy, on a dietary supplement sold at retail, and on a vial marked "for research use only" sold online. The word is identical; the accountability is not remotely.

Sellers in the least regulated category benefit from that confusion, and some cultivate it.

A prescriber evaluates you, decides a product is appropriate, and a licensed pharmacy dispenses it. Product is either FDA-approved or compounded under a specific statutory exemption. There is a named prescriber, a named pharmacy, a label with your name on it, lot numbers and a beyond-use date.

If something goes wrong, there is a chain of professional accountability — state boards, adverse event reporting, malpractice exposure. That chain is the actual product you are buying.

Dietary supplements are regulated, but through a framework that does not require premarket approval. Manufacturers are responsible for safety and for truthful labelling, must follow supplement cGMP, and must confine themselves to structure/function claims.

FDA acts mainly after the fact. That means quality varies more than in the prescription channel, and third-party testing becomes the practical substitute for premarket review.

Material labelled for research use only is sold outside the human-use framework entirely. No supplement cGMP, no dispensing pharmacist, no medical oversight, frequently no meaningful quality documentation.

The label is doing legal work rather than describing an intended customer. That is discussed in more detail in our piece on the research-use loophole.

Is a licensed prescriber involved? Is a named, verifiable pharmacy dispensing it? Does the packaging carry a Supplement Facts panel and an FDA disclaimer? Does it say "not for human consumption" anywhere? Is there a lot number and an expiry date? Is there a real company address and phone number?

Those six questions place almost any product correctly, and the last two fail surprisingly often.